EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.5000
+0.0350 (7.53%)
Aug 5, 2026, 4:10 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 23.53 million as of August 5, 2026. Its market cap has decreased by -75.66% in one year.
Market Cap
23.53M
Enterprise Value
8.98M
Revenue
61.40M
Ranking
n/a
PE Ratio
8.15
Stock Price
0.50
ChartMarket Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 23.53M, a decrease of -51.70%. That is a compound annual growth rate of -12.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 23.53M | -64.52% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imugene | 35.76M |
| Noxopharm | 27.04M |
| Proteomics International Laboratories | 26.43M |
| Algorae Pharmaceuticals | 24.31M |
| NeuroScientific Biopharmaceuticals | 24.16M |
| Patrys | 22.00M |
| Argenica Therapeutics | 19.91M |
| Neurotech International | 19.77M |